Introduction
The status of internal mammary lymph nodes of breast cancer is an important parameter to determine regional lymph node staging, to predict accurate prognosis, and to guide suitable adjuvant therapy for patients. [1] [2] [3] [4] The American Joint Committee on Cancer staging manual has placed special emphasis on the role of status of the internal mammary lymph nodes in the regional lymph node staging of breast cancer. 5 In this study, we evaluated the feasibility of robot-assisted internal mammary lymph node chain dissection by the Da Vinci robot-assisted surgical system (Intuitive Surgical, Sunnyvale, CA).
Patients and Methods

Patients
From May 2015 to November 2017, after receipt of approval from the local ethics committee, 13 patients with suspected internal mammary lymph node metastasis demonstrated by computed tomography, positron emission tomographyecomputed tomography, or ultrasound and without distant metastases were included ( Figure 1 ). After informed consent was obtained, 13 patients were available for enrollment onto the study. Five of these subjects had left breast cancer. The mean age was 46.5 years (range, 37-62 years). Before the operation, carbon nanoparticles in suspension (Chongqing Lummy Pharmaceutical, Chongqing, China) were injected into 4 depots surrounding the primary tumor or next to the biopsy scar, with about 0.1 mL injected at each point.
The research ethics committee of Jinan Military General Hospital of People's Liberation Army granted approval (no. 2016-28), and preoperative written informed consent was obtained from all patients.
Surgical Technique
After induction of general anesthesia using a double-lumen endotracheal tube, and sterile draping of the patient, an
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Internal mammary node biopsy is important for us to make an appropriate locoregional lymph node staging and treatment decision. However, till now, there is no an ideal method to detect out metastatic nodes in internal mammary lymph chain exactly. Thoracoscopic internal mammary lymph chain dissection has been reported, but it is difficult to remove the left internal mammary nodes by this technique. Our study indicated that robotic internal mammary node dissection is a feasible, minimally invasive and simple procedure, which can improve nodal staging and be used to treat patients with left sided internal mammary lymph metastases which may spared patients getting adjuvant radiation therapy and its subsequent effects on the heart. The robotic internal mammary lymph chain dissection is sometimes recommended for tumors !5 cm, or axillary lymph nodes positive, positive surgical margins, or suspected internal mammary lymph node metastasis by CT, positron emission tomographycomputed tomography examination, or ultrasonography examination.
incision was made in the predetermined line for mastectomy. Patients first underwent modified radical mastectomy, breastconserving surgery, or sentinel lymph node biopsy. Robotassisted internal mammary lymph node chain dissection was then performed.
Single-lung ventilation using a double-lumen endotracheal tube that permits collapse of right or left lung was performed during the operation. The patient was placed in a semioblique position supported by an inflatable pillow. Two trocars were introduced through 2 thoracic incisions at the third and seventh intercostal spaces along the midaxillary line for placement of Maryland dissectors and Harmonic curved shears. Another trocar was introduced through a thoracic incision at the fifth (or fourth) intercostal spaces along the anterior axillary line or the midaxillary line for placement of the camera. The distance between each trocar was > 6 cm ( Figures 2-4 ). The camera was used for visualization of the thoracic cavity, identification and exposure of the internal mammary artery, and visualization of black-dyed internal mammary lymph nodes. The position of the camera port and working ports can be modified as required for optimal visualization or to facilitate manipulation of the instruments.
The surgeon sat at the control table to operate the robotic system to complete the surgery. The first step of the procedure was to expose the internal mammary artery and vein. The right internal mammary artery could be identified easily just distal to its origin of the subclavian artery; the black-dyed node and lymphatic chain could be identified easily, as they were covered only by a thin parietal pleura ( Figure 5 ). The left internal mammary artery was sometimes covered by pericardial fat, the aorta, or pleural adhesions. 
Robot-Assisted Internal Mammary Dissection
The parietal pleura was incised at 1.5 cm away from the external border of the artery with Harmonic curved shears. Maryland dissectors or Prograsp forceps allowed retraction of the pleura and mobilization of the arterial pedicle. The collaterals were clipped or coagulated. The distal parts of the internal mammary vessels and all collateral branches issuing from the vessels were transected with Harmonic curved shears. This technique facilitated a complete dissection of the internal mammary lymphatic chain from the first rib to the sixth rib ( Figure 6 ). Bagged specimen was extracted through the 12 mm trocar. After removing the internal mammary lymphatic chain, the surgical field was douched by 1000 mL sterile distilled water (42 C). In 5 patients, a thoracic drainage tube was placed. The lung was fully expanded by opening the double-lumen endotracheal tube. Thoracic incisions were closed in layers.
Individualized treatment was performed according to the clinical pathologic disease stage and molecular typing results of the breast cancer.
Results
Robot-assisted internal mammary lymph node chain dissection was successfully performed in 13 patients; this included 2 cases of breast-conserving surgery and 11 cases of modified radical mastectomy. Exposure of local anatomic condition was adequate with the 30-degree 3-dimensional imaging system positioned in the fifth (or fourth) intercostal space in the anterior axillary line. The mean duration of the procedure was 28.2 AE 10.6 minutes (range, 20-45 minutes). A total of 75 internal mammary lymph nodes were removed from the 13 patients (5.8 AE 2). Nine patients had internal mammary lymph node metastasis, and improved nodal staging with internal mammary nodal metastasesPostoperative pathology confirmed that 9 patients out of the 13 patients had internal mammary lymph node metastasis, and which improved nodal staging for the 9 patients. All the internal mammary lymph nodes were located at the area from the subclavian artery to the fourth intercostal spaces. There was no damage to the lungs, no intraoperative or postoperative bleeding, no pulmonary atelectasis, and no pulmonary infection. No patients required reoperation for postoperative complications.
All patients had been followed up (average, 16.5 months; range, 2-33 months) on a regular basis. Local recurrence, distant metastasis, or obvious discomfort was not reported.
Discussion
As a first-echelon nodal drainage site in breast cancer, the status of axillary lymph nodes and internal mammary lymph nodes is valuable both for regional lymph node staging and treatment choice. Internal mammary nodal metastases are reported to be present in 24.5% of patients with breast cancer, mostly concomitant with axillary metastases. Metastases exclusively situated in the internal mammary chain occur in 6.15% of patients. 4 Patients with internal mammary lymph nodes metastases had a worse prognosis than those who did not, independent of their axillary lymph nodes status. The prognosis of patients with internal mammary lymph nodes metastases only was similar to those with axillary lymph nodes metastases only. National Comprehensive Cancer Network (NCCN) guidelines recommend irradiation of infraclavicular and supraclavicular areas, internal mammary lymph nodes, and any part of the axillary bed that may be suspicious (category 1 for ! 4 positive axillary lymph nodes; category 2A for 1-3 positive axillary lymph nodes nodes). 6 Nevertheless, the extended radical mastectomy was abandoned in the 1970s not only as a staging procedure (resulting from the low rate of internal mammary metastases in the absence of axillary metastases) but also as a therapeutic procedure (because removal of all internal mammary lymph node did not improve survival). 7, 8 An important drawback of extended radical mastectomy is the trauma. Internal mammary lymph node biopsy might be necessary to obtain complete staging information in order to make an appropriate locoregional lymph node staging and treatment decisions, especially in patients with axillary nodeenegative disease. Internal mammary sentinel lymph node biopsy plays an important role in locoregional lymph node staging of breast cancer according to the criteria of the 2010 American Joint Committee on Cancer. 9 Up till now, there has been no ideal method to exactly detect metastatic nodes in the internal mammary lymph chain. Thoracoscopic internal mammary lymph chain dissection has been reported, but with this technique, it is difficult to remove the left internal mammary lymph nodes. 10 If nodal staging is performed with only axillary nodal information, 25% to 40% of the time staging may be inaccurate; radiotherapy after operation on the internal mammary region may also result in overtreatment or inadequate treatment. 11, 12 Too much radiotherapy may lead to impaired function of the heart, lungs, and great vessels. To reduce the risk of local recurrence, the NCCN recommends radiotherapy to the chest wall and the supraclavicular region. If the internal mammary lymph node is clinically or pathologically involved, radiotherapy should include the internal mammary lymph nodes. If the internal mammary lymph nodes are not clinically or pathologically involved, then including the internal mammary lymph nodes in the radiotherapy field is at the discretion of the treating radiation oncologist (category 3). 6 These results emphasize the need for a better surgical technique if internal mammary lymph node dissection becomes part of breast cancer staging. 13 The robot-assisted procedure can access all areas along the internal mammary chain by additional small, inconspicuous skin incisions. Robot-assisted internal mammary lymph node chain dissection is a minimally traumatic procedure that results in good cosmesis. 14, 15 Patients with disease-positive internal mammary lymph nodes may have their disease upstaged, which may make a difference in their adjuvant treatment. Moreover, this dissection technique can be used to treat patients with left-sided internal mammary lymph node metastases, which may spare patients from receiving adjuvant radiotherapy and its subsequent effects on the heart. Robot-assisted internal mammary lymph node chain dissection in breast cancer is technically feasible and can improve nodal staging. Local anatomic conditions are easily discerned by the excellent 3-dimensional visualization as well as by the stable and magnified operative view. This technique is contraindicated in certain patients with severe pulmonary diseases who are unable to accept single-lung ventilation. Patient selection for robot-assisted internal mammary lymph node chain dissection may increase the potential benefit of the technique. It improves pN staging with internal mammary nodal metastases. Robot-assisted internal mammary lymph node chain dissection is sometimes recommended for tumors ! 5 cm or for positive axillary lymph nodes, positive surgical margins, or suspected internal mammary lymph node metastasis by computed tomography, positron emission tomographyecomputed tomography, or ultrasound. However, this operative procedure also has some disadvantages, such as longer operation times, use of CO 2 insufflation, no force or haptic feedback, and higher costs. Large series studying this technique are needed to identify the best candidates for robot-assisted internal mammary lymph node chain dissection. 14, 15 
